VivianAndrewFonsecaMD
Endocrinology • New Orleans, LADiabetes, Lipid Metabolism
Professor of Medicine, Tulane University
Dr. Fonseca is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1430 Tulane Ave
Slip 53
New Orleans, LA 70112Phone+1 504-988-4026Fax+1 504-988-6271
Education & Training
Tulane University School of MedicineClass of 1974
Certifications & Licensure
LA State Medical License 1998 - 2024
AR State Medical License 1993 - 2022
NY State Medical License 1993 - 2018- American Board of Internal Medicine Endocrinology, Diabetes and Metabolism
Awards, Honors, & Recognition
- Regional Top Doctor Castle Connolly, 2014
- CMS Meaningful Use Stage 1 Certification eClinicalWorks EHR, eClinicalWorks LLC, 2012-2013
- Super Doctor SuperDoctors.com
- Join now to see all
Clinical Trials
- Targeting INflammation Using SALsalate in Type 2 Diabetes (TINSAL-T2D) Start of enrollment: 2006 Oct 01
- Comparison of Insulins Aspart and Lispro in Insulin Pumps Start of enrollment: 2004 Oct 01
- Study of Metanx® in Subjects With Type 2 Diabetic Peripheral Neuropathy (DPN) Start of enrollment: 2008 Jun 01
- Join now to see all
Publications & Presentations
PubMed
- 227 citationsFifty-two-week efficacy and safety of vildagliptin vs. glimepiride in patients with type 2 diabetes mellitus inadequately controlled on metformin monotherapyEleuterio Ferrannini, Vivian Fonseca, B. Zinman, D. R. Matthews, Bo Ahrén
Diabetes, Obesity & Metabolism. 2009-02-01 - 121 citationsEffect of Intensive Compared With Standard Glycemia Treatment Strategies on Mortality by Baseline Subgroup Characteristics: The Action to Control Cardiovascular Risk i...Jorge Calles-Escandon, Laura C. Lovato, Denise G. Simons-Morton, David M. Kendall, Rodica Pop-Busui
Diabetes Care. 2010-04-01 - 31 citationsIntensive Risk Factor Management and Cardiovascular Autonomic Neuropathy in Type 2 Diabetes: The ACCORD Trial.Yaling Tang, Hetal Shah, Carlos Bueno Junior, Xiuqin Sun, Joanna Mitri
Diabetes Care. 2021-01-01
Journal Articles
- Weight Loss in Underserved Patients — A Cluster-Randomized TrialEboni G Price-Haywood, Tina K Thethi, Vivian Fonseca, Jonathan Gugel, Benjamin Springgate, New England Journal of Medicine
- Potential Role of Metal Chelation to Prevent the Cardiovascular Complications of DiabetesVivian Fonseca, David M Nathan, Jonathan Newman, The Journal of Clinical Endocrinology and Metabolism
- GLP-1 Receptor in Pancreatic Α Cells Regulates Glucagon Secretion in a Glucose-Dependent Bidirectional MannerWeiwei Xu, Vivian A Fonseca, Diabetes Care
Lectures
- The Intersection of Heart Failure and Diabetes2019 ACC Scientific Session & Expo, New Orleans - 3/16/2019
- A Model‐Based Meta‐Analysis of 24 Antihyperglycemic Drugs for Type 2 Diabetes: Comparison of Treatment Effects at Therapeutic DosesVivian Fonseca, MD - 6/13/2014
- A Model‐Based Meta‐Analysis of 24 Antihyperglycemic Drugs for Type 2 Diabetes: Comparison of Treatment Effects at Therapeutic DosesNew Orleans, LA - 6/15/2014
Press Mentions
Ozempic Shortage: How a Weight Loss Fad Has Slashed Access to a Diabetes DrugOctober 28th, 2022- Fractyl Health Provides Initial Clinical Update on Open-Label REVITA-T2DiJanuary 18th, 2022
- Fractyl Announces Tenth Trial Site Opened in REVITA-T2Di Study of Revita® DMR for Type 2 DiabetesSeptember 1st, 2021
- Join now to see all
Committees
- member, AACE/ACE Comprehensive Type 2 Diabetes Management Algorithm 2026
- member, CONSENSUS STATEMENT BY THE AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY ON THE COMPREHENSIVE TYPE 2 DIABETES MANAGEMENT ALGORITHM 2016 EXECUTIVE SUMMARY
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
